Sex Difference in Chronic Obstructive Lung Disease. Does it Matter? A Concise Review

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 6, 2016, Pages 799-806

  Kokturk, Nurdan ^a   Kilic, Hatice ^b   Baha, Ayse ^c   Lee, S D ^d   Jones, Paul W ^e  

^a GAZI UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c UFUK UNIVERSITY   (Turkey)

^d University of Ulsan College of Medicine   (South Korea)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

clinical presentation; COPD; exacerbation; female; gender; treatment

Indexed keywords

RESPIRATORY TRACT AGENT;

BIOMASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; DISEASE EXACERBATION; DISTRESS SYNDROME; DYSPNEA; EXPOSURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUME; HEART FAILURE; HUMAN; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; INHALER; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG CANCER; MORTALITY RATE; OSTEOPOROSIS; PASSIVE SMOKING; PRIORITY JOURNAL; PULMONARY REHABILITATION; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SMOKE; SMOKING CESSATION; COMPLICATION; DISEASE PREDISPOSITION; FEMALE; MALE;

COMORBIDITY; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS;

EID: 84996602597     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412555.2016.1199666     Document Type: Review

References (82)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Red SC. Chronic obstructive pulmonary disease surveillance:United States, 1971–2000. MMWR Surveill Summ 2002; 51:1–16.
2. Varkey AB. Chronic obstructive pulmonary disease in women:exploring sex differences. Curr Opin Pulm Med 2004; 10:98–103.
3. Aryal S, Diaz-Guzman E, Mannino DM. COPD and sex differences:an update. Transl Res 2013; 162(4):208–218.
4. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD Gene Study. Am J Respir Crit Care Med 2011; 184(4):414–420.
5. Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J 2011; 20(4):370–378.
6. Aryal S, Diaz- Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J COPD 2014; 9:1145–1154.
7. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study):a population-based prevalence study. Lancet 2007; 370:741–750.
8. Ben-Zaken Cohen S, Paré, PD, Man SF, Sin DD. The growing burden of chronic obstructive pulmonary disease and lung cancer in women examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007; 176(2):113–120.
9. Camp PG, Goring SM. Sex and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2007; 4(8):686–691.
10. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000; 53(7):755–761.
11. Deveci F, Deveci SE, Turkoglu S, Turgut T, Kirkil G, Rahman S, et al. The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey. Eur J Intern Med 2011; 22(2):172–176.
12. Camp PG, Chaudhry M, Platt H, Roch M, Road J, Sin D, et al. The sex factor:Epidemiology and management of chronic obstructive pulmonary disease in British Columbia. Can Respir J 2008; 15(8):417–422.
13. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative. Int J Tuberc Lung Dis 2008; 12(7):703–708.
14. Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, et al. Chronic obstructive pulmonary disease mortality and prevalence:the associations with smoking and poverty-a BOLD analysis. Thorax 2014; 69:465–473.
15. Mackay J, Amos A. Invited review series:Tobacco and lung health. Women and tobacco. Respirology 2003; 8(2):123–130.
16. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American thoracic society public policy statement:Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182(5):693–718.
17. Vijayan CV. Chronic obstructive pulmonary disease. Indian J Med Res 2013; 137(2):251–269.
18. Zhou Y, Chen R. Risk factors and intervention for chronic obstructive pulmonary disease in China. Respirology 2013; 18(3):4–9.
19. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries:a major environmental and public health challenge. Bull World Health Organ 2000; 78:1078–1092.
20. Idolor LF, De Guia TS, Francisco NA, Roa CC, Ayuyao FG, Tady CZ, et al. Burden of obstructive lung disease in a rural setting in the Philippine. Respirology 2011; 16(7):1111–1118.
21. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E, et al. Prevalence of COPD:First epidemiological study of a large region in Turkey. Eur J Intern Med 2008; 19(7):499–504.
22. Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et al. Vulnerability of patients with chronic obstructive pulmonary disease according to sex in China. Int J Chron Obstruct Pulmon Dis 2012; 7:825–832.
23. Smith M, Li L, Augustyn M, Kurmi O, Chen J, Collins R, et al. Prevalence and correlates of airflow obstruction in,317 000 never-smokers in China. Eur Respir J 2014; 44(1):66–77.
24. Cote CG, Chapman KR. Diagnosis and treatment considerations for women with COPD. Int J Clin Pract 2009; 63(3):486–493.
25. Perez-Padilla JR. Exposure to biomass smoke and chronic airways disease in Mexican women. A case-control study. Am J Respir Crit Care Med 1996; 154:701–706.
26. Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds RF, et al. Cigarette smoking and exposure to environmental tobacco smoke in China:the international collaborative study of cardiovascular disease in Asia. Am J Public Health 2004; 94:1972–1976.
27. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers:a descriptive study. Am J Respir Crit Care Med 2002; 166(8):1078–1083.
28. http://w3.whosea.org/women/chap3_1f.htm.
29. http://w3.whosea.org/women/ch7f.htm
30. Vollmer WM, Enright PL, Pedula KL, Speizer F, Kuller LH, Kiley J, et al. Race and Gender Differences in the Effects of Smoking on Lung Function. Chest 2000; 117:764–772.
31. Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Racial and sex differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 2006; 100:1110–1116.
32. Barbee RA. The effects of sex on the development of chronic obstructive pulmonary disease. Respiration 2006; 73:279.
33. Kamil F, Pinzon I, Foreman MG. Sex and race factors in early-onset COPD. Curr Opin Pulm Med 2013; 19:140–144.
34. Kirkpatrick NP, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009; 15:100–104.
35. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, et al. Sex-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:2152–2158.
36. Jordan RE, Miller MR, Lam KH, Cheng KK, Marsh J, Adab P. Sex, susceptibility to smoking and chronic obstructive pulmonary disease:the effect of different diagnostic criteria. Analysis of the Health Survey for England. Thorax 2012; 67:600–605.
37. Tam A, Churg A, Wright JL, Zhou S, Kirby M, Coxson HO, et al. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016; 193(8):825–834.
38. Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, et al. Sex differences in plasma biomarker levels in a cohort of COPD Patients:A Pilot Study. PLoS ONE 2011; 6(1):e16021.
39. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martín A, et al. Attitude toward the diagnosis of chronic obstructive pulmonary disease in primary care [in Spanish]. Arch Broncopneumol 2006; 42:3–8.
40. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006; 28:319–322.
41. Ancochea J, Miravitlles M, Garcia-Rio F, Luis, Muñoz, Guadalupe S, Víctor S, et al. Under-diagnosis of chronic obstructive pulmonary disease in women:quantification of the problem, determinants and proposed actions. Arch Bronconeumol 2013; 49:223–229.
42. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA, Jr. Sex differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med 2005; 12:1173–1179.
43. Raine R, Goldfrad C, Rowan K, Black N. Influence of patient sex on admission to intensive care. J Epidemiol Community Health 2002; 56:418–423.
44. Martinez CH, Raparla S, Plauschinat CA, Giardino ND, Rogers B, Beresford J, et al. Sex differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) 2012; 21(12):1267–1274.
45. Katsura H, Yamada K, Wakabayashi V. Sex-associated differences in dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2007; 12:427–432.
46. Roche N, Deslée G, Caillaud D, Brinchault G, Court-Fortune I, Nesme-Meyer P, et al. Impact of gender on COPD expression in a real-life cohort. Roche N. Respir Res 2014; 15:20.
47. Tödt K, Skargren E, Kentson M, Theander K, Jakobsson P, Unosson M. Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD. Int J COPD 2014; 9:17–25.
48. Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, et al. Predictors of lung function and its decline in mild to moderate COPD in association with sex:Resultsfrom the Euroscop study. Respir Med 2006; 100(4):746–753.
49. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31:869–873.
50. Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med 2011; 183(3):317–322.
51. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 2012; 106(3):367–373.
52. Gonzalez AV, Suissa S, Pierre Ernst P. Sex differences in survival following hospitalisation for COPD. Thorax 2011; 66:38–42.
53. Gan WQ, Man SFP, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease:a systematic review and meta-analysis. Respir Res 2006; 7:52.
54. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, et al. Sex Differences in Severe Pulmonary Emphysema. Am J Respir Crit Care Med 2007; 176(3):243–252.
55. Hardin M, Foreman M, Dransfield MT, Hansel N, Han MK, Cho MH, et al. Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J 2016; 47:104–112.
56. Machado MC, Krishnan JA, Buist SA, et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174(5):524–529.
57. Han MK, Postma D, Mannino DM, Bilderback AL, Fazolo GP, Santarosa MG, et al. Sex and chronic obstructive pulmonary disease why it matters. Am J Respir Crit Care Med 2007; 176(12):1179–1184.
58. Lahm T. Sex differences in COPD. Eur Respir J 2009; 34(1):288–289.
59. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122.
60. Almagro P, LópezGarcía F, Cabrera FJ, Montero L, Morchón D, Díez J, et al. Comorbidity and sex-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010; 104(2):253–259.
61. Carrasco-Garrido P, de Miguel-Díez J, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V, et al. Characteristics of chronic obstructive pulmonary disease in Spain from a sex perspective. BMC Pulm Med 2009; 9:2.
62. Ekström MP, Jogréus C, Ström KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS ONE 2012; 7:e35806.
63. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132(1):148–155.
64. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients:The roles of sex and disease severity. Respir Med 2006; 100(10):1767–1774.
65. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163(10):1180–1186.
66. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11(2):188–195.
67. Kilic H, Kokturk N, Sarı G, Cakir M. Do females behave differently in COPD exacerbations? Int J COPD 2015; 10:823–830.
68. Sunyer J, Antó, JM, McFarlane D, Domingo A, Tobías A, Barceló MA, et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(3):851–856.
69. Panday S, Reddy SP, Ruiter RA, Bergström E, de Vries H. Nicotine Dependence and Withdrawal Symptoms among Occasional Smokers. J Adolesc Health 2007; 40(2):144–150.
70. Scharf D, Shiffman S. Are there sex differences in smoking cessation, with and without bupropion? Pooled and meta-analyses of clinical trials of Bupropion SR. Addiction 2004; 99(11):1462–1469.
71. Bjornson W, Rand C, Connett JE, Lindgren P, Nides M, Pope F, et al. Sex differences in smoking cessation after 3 years in the lung health study. Am J Public Health 1995; 85(2):223–230.
72. Gritz ER, Nielsen IR, Brooks LA. Smoking cessation and sex:the influence of physiological, psychological, and behavioral factors. J Am Med Womens Assoc 1996; 51(1–2):35–42.
73. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161(2):381–390.
74. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture:a population-based case-control study. Am J Respir Crit Care Med 2002; 166(12 Pt 1):1563–1566.
75. Pauwels RA, Löfdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340(25):1948–1953.
76. Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P. Sex does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med 2004; 98(11):1045–1050.
77. Schermer TR, Hendriks AJ, Chavannes NH, Dekhuijzen PNR, EFM, van den Hoogen H, et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J 2004; 13:48–55.
78. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006; 19(2):127–136.
79. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and sex on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994; 150:1256–1261.
80. Hashmi A, Soomro JA, Menon A, Soomro TK. Incorrect inhaler technique compromising quality of life of asthmatic patients. J Med 2012; 13:16–21.
81. Haggerty MC, Stockdale-Woolley R, ZuWallack R. Functional status in pulmonary rehabilitation participants. J Cardiopulm Rehabil 1999; 19(1):35–42.
82. Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Sex moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001; 119(1):70–76.